Regulatory management option analysis
The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.
For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.
RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Further information
Last updated 12 diciembre 2019. Database contains 224 unique substances/entries.
211-765-7 | 693-98-1 | Sweden | Toxic for reproduction | Under development | Under development | No suggestion yet | 10/04/2018 | Details | |
202-112-7 | 91-97-4 | Germany | Mutagenic Persistence Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
223-861-6 | 4098-71-9 | Sweden | Exposure Mutagenic Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | None | 09/02/2018 | Details | |
223-861-6 | 4098-71-9 | Germany | Carcinogenic Exposure Mutagenic Other human toxicity | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 10/10/2019 | Details | |
201-025-1 | 77-40-7 | France | Endocrine disruption | Under development | Under development | No suggestion yet | 07/03/2017 | Details | |
216-036-7 | 1478-61-1 | Sweden | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | CLH | 20/12/2018 | Details | |
Bisphenol A; BPA | 201-245-8 | 80-05-7 | Germany | Aggregated tonnage Endocrine disruption Widespread use | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 15/08/2017 | Details |
Bisphenol A; BPA | 201-245-8 | 80-05-7 | France | Endocrine disruption Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 15/08/2017 | Details |
226-378-9 | 5384-21-4 | France | Endocrine disruption Persistence Toxic for reproduction Widespread use | Under development | Under development | No suggestion yet | 11/03/2016 | Details | |
225-863-2 | 5124-30-1 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
210-658-2 | 620-92-8 | Sweden | Endocrine disruption Other human toxicity | Under development | Under development | No suggestion yet | 01/10/2015 | Details | |
202-966-0 | 101-68-8 | Germany | Respiratory sensitiser Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 23/09/2014 | Details | |
202-966-0 | 101-68-8 | Denmark | Carcinogenic Mutagenic Other human toxicity Persistence Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 23/09/2014 | Details | |
254-551-9 | 39635-79-5 | Denmark | Carcinogenic Mutagenic Toxic for reproduction | Pending | On hold | No suggestion yet | 10/10/2019 | Details | |
201-250-5 | 80-09-1 | Belgium | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 06/03/2015 | Details | |
250-863-4 | 31906-04-4 | Sweden | Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | Other | 05/06/2015 | Details | |
202-681-1 | 98-56-6 | Netherlands | Carcinogenic | Under development | Under development | No suggestion yet | 09/11/2017 | Details | |
209-544-5 | 584-84-9 | Denmark | Aggregated tonnage Carcinogenic Exposure Mutagenic Widespread use | Concluded | No need to initiate further regulatory risk management action at this time | None | 10/10/2019 | Details | |
209-544-5 | 584-84-9 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 10/10/2019 | Details | |
202-696-3 | 98-73-7 | Belgium | Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 23/09/2014 | Details | |
202-679-0 | 98-54-4 | Germany | Endocrine disruption Other human toxicity Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/10/2019 | Details | |
400-370-7 | - | Finland | Bioaccumulation Other environmental toxicity Persistence | Under development | Under development | No suggestion yet | 05/09/2019 | Details | |
217-533-1 | 1879-09-0 | France | Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction | Under development | Under development | No suggestion yet | 07/03/2017 | Details | |
255-288-2 | 41272-40-6 | Netherlands | Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 15/12/2017 | Details | |
235-715-9 | 12607-70-4 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 23/09/2014 | Details | |
201-469-6 | 83-32-9 | France | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 11/12/2015 | Details | |
203-466-5 | 107-13-1 | Germany | Mutagenic Other human toxicity Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 23/09/2014 | Details | |
287-477-0 | 85535-85-9 | Germany | Carcinogenic Toxic for reproduction | Under development | Under development | No suggestion yet | 08/07/2019 | Details | |
287-477-0 | 85535-85-9 | United Kingdom | Bioaccumulation Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC Restriction | 12/12/2019 | Details | |
- | - | Netherlands | Carcinogenic Exposure Mutagenic STOT RE | Under development | Under development | No suggestion yet | 13/04/2017 | Details | |
292-562-0 | 90640-43-0 | Sweden | STOT RE | Concluded | No need to initiate further regulatory risk management action at this time | None | 17/04/2019 | Details | |
This substance is identified by SDA Substance Name: N-C12-C18 alkyl propylene diamine and SDA Reporting Number: 16-032-00. | 268-957-9 | 68155-37-3 | Sweden | Carcinogenic Mutagenic Respiratory sensitiser Skin sensitiser Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 17/04/2019 | Details |
696-364-9 | 133779-11-0 | Sweden | STOT RE | Concluded | No need to initiate further regulatory risk management action at this time | None | 17/04/2019 | Details | |
232-565-6 | 9000-90-2 | United Kingdom | Respiratory sensitiser Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | Other | 12/09/2018 | Details | |
200-539-3 | 62-53-3 | Netherlands | Other environmental toxicity Other human toxicity | Concluded | No need to initiate further regulatory risk management action at this time | None | 05/07/2017 | Details | |
233-660-5 | 10294-40-3 | Netherlands | Carcinogenic | Concluded | Appropriate to initiate regulatory risk management action | CLH SVHC | 08/07/2019 | Details | |
200-280-6 | 56-55-3 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
trimellitic anhydride; TMA | 209-008-0 | 552-30-7 | Netherlands | Mutagenic Skin sensitiser Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 11/03/2016 | Details |
205-883-8 | 191-24-2 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
205-916-6 | 207-08-9 | Germany | Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/07/2017 | Details | |
231-150-7 | 7440-41-7 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other | 19/12/2016 | Details | |
215-133-1 | 1304-56-9 | Netherlands | Carcinogenic | Under development | Under development | No suggestion yet | 09/11/2017 | Details | |
229-176-9 | 6422-86-2 | France | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 25/01/2019 | Details | |
223-445-4 | 3896-11-5 | Germany | Carcinogenic Mutagenic Toxic for reproduction | Under development | Under development | No suggestion yet | 05/12/2014 | Details | |
207-069-8 | 431-03-8 | Netherlands | Carcinogenic | Under development | Under development | No suggestion yet | 09/11/2017 | Details | |
208-168-9 | 513-78-0 | Sweden | Carcinogenic Mutagenic STOT RE Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 09/06/2017 | Details | |
232-222-0 | 7790-79-6 | Sweden | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 23/09/2014 | Details | |
244-168-5 | 21041-95-2 | Sweden | Carcinogenic Mutagenic STOT RE Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 09/06/2017 | Details | |
233-710-6 | 10325-94-7 | Sweden | Carcinogenic Mutagenic STOT RE Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 09/06/2017 | Details | |
233-331-6 | 10124-36-4 | Sweden | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 23/09/2014 | Details | |
Route: .live2